Elizabeth Hamilton Seabury Wyatt
Directeur/Membre du Conseil chez Randolph-Macon College
Profil
Dr. Elizabeth H.
Wyatt is Lead Independent Director at The Medicines Co. She is on the Board of Directors at The Medicines Co., Randolph-Macon College, Sweet Briar College, and Serenex, Inc.
Dr. Wyatt was previously employed as Vice President-Corporate Licensing by Merck & Co., Inc. and Non-Executive Director by Norwood Abbey Ltd.
She also served on the board at ARIAD Pharmaceuticals, Inc., MedImmune LLC, and Neose Technologies, Inc.
She received her undergraduate degree from Sweet Briar College, a graduate degree from Boston University, and an MBA from Harvard Business School.
Postes actifs de Elizabeth Hamilton Seabury Wyatt
| Sociétés | Poste | Début |
|---|---|---|
| Randolph-Macon College | Directeur/Membre du Conseil | - |
| Sweet Briar College | Directeur/Membre du Conseil | - |
Anciens postes connus de Elizabeth Hamilton Seabury Wyatt
| Sociétés | Poste | Fin |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/12/2008 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Directeur/Membre du Conseil | 21/06/2007 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2000 |
Norwood Abbey Ltd.
 Norwood Abbey Ltd. Pharmaceuticals: OtherHealth Technology Norwood Abbey Ltd. develops and commercializes innovative projects and technologies that address needs in the medical industry. The company has two divisions: Devices and Immunology. The Devices division manufactures and sells medical devices. The Immunology division is engaged in the development of products relating to the enhancement of the human immune system. The company was founded on November 13, 1998 and is headquartered in Frankston, Australia. | Directeur/Membre du Conseil | - |
Serenex, Inc.
 Serenex, Inc. Pharmaceuticals: MajorHealth Technology Serenex, Inc. operates as a biotechnology company that develops drugs for tumors and cancers of the blood and bone marrow. Its products include drugs for chemotherapy treatments as well as inhibitor compounds. Serenex was founded by George Young and Timothy Haystead in 2000 and is headquartered in Durham, NC. | Directeur/Membre du Conseil | - |
Formation de Elizabeth Hamilton Seabury Wyatt
| Sweet Briar College | Undergraduate Degree |
| Boston University | Graduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Neose Technologies, Inc.
 Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market. | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Serenex, Inc.
Serenex, Inc. Pharmaceuticals: MajorHealth Technology Serenex, Inc. operates as a biotechnology company that develops drugs for tumors and cancers of the blood and bone marrow. Its products include drugs for chemotherapy treatments as well as inhibitor compounds. Serenex was founded by George Young and Timothy Haystead in 2000 and is headquartered in Durham, NC. | Health Technology |
Norwood Abbey Ltd.
Norwood Abbey Ltd. Pharmaceuticals: OtherHealth Technology Norwood Abbey Ltd. develops and commercializes innovative projects and technologies that address needs in the medical industry. The company has two divisions: Devices and Immunology. The Devices division manufactures and sells medical devices. The Immunology division is engaged in the development of products relating to the enhancement of the human immune system. The company was founded on November 13, 1998 and is headquartered in Frankston, Australia. | Health Technology |
